-
Market Watch: Mylan (NASDAQ:MYL), Vale S.A. (NYSE:VALE), MAXIMUS (NYSE:MMS), Pacific Mercantile Bancorp (NASDAQ:PMBC), Vocera Communications (NYSE:VCRA)
Mylan Inc. (NASDAQ:MYL) reported net earnings for the fourth quarter of $189.2 million or $0.47 per share, compared to $180.2 million or $0.45 per share for the year-ago quarter. Excluding items, adjusted net earnings for the fourth quarter was $419.8 million or $1.05 per share, compared to $308.1 million or $0.78 per share in the…
-
Hot Watch List: Jiayuan.com International (NASDAQ:DATE), Mylan (NASDAQ:MYL), Extreme Networks Inc. (NASDAQ:EXTR), Newcastle Investment Corp. (NYSE:NCT), Gigamon Inc. (NYSE:GIMO)
Jiayuan.com International Ltd. (NASDAQ:DATE), announced that its Board of Directors has received a preliminary non-binding proposal letter, dated March 3, 2015from Vast Profit Holdings Limited that proposes a “going-private” transaction involving the acquisition of all of the outstanding ordinary shares of the Company not already owned by Vast Profit at a price per share of…
-
Stocks News Alert: Oracle Corporation (NYSE:ORCL), Synacor (NASDAQ:SYNC), Plains GP Holdings, L.P. (NYSE:PAGP), Comcast Corporation (NASDAQ:CMCSA), Mylan (NASDAQ:MYL)
Oracle Corporation (NYSE:ORCL) launched the Oracle Hospitality Global Business unit in its efforts to enhance the development of cloud and mobile technology for its hospitality customers. On Monday shares of Oracle Corporation (NYSE:ORCL) closed at $43.77. Company’s sales growth for last 5 years was 10.50% and EPS growth for next 5 years is recorded as…
-
Notable Stocks in Focus: Key Energy Services Inc. (NYSE:KEG), SunEdison (NYSE:SUNE), Radiant Logistics (NYSEMKT:RLGT), Eagle Bancorp Montana (NASDAQ:EBMT), Mylan (NASDAQ:MYL)
Key Energy Services, Inc. (NYSE:KEG) will report fourth quarter and full-year 2014 financial results after market close on Wednesday, February 18, 2015, and Key management will host a conference call to discuss these results on Thursday, February 19, 2015 at 10:00 a.m. CST. On Monday shares of Key Energy Services Inc. (NYSE:KEG) closed at $2.39.…
-
Investors Alert: CollabRx (NASDAQ:CLRX), Lifevantage Corporation (NASDAQ:LFVN), Corcept Therapeutics Incorporated (NASDAQ:CORT), Mylan (NASDAQ:MYL), BIND Therapeutics (NASDAQ:BIND)
On 22 January CollabRx, Inc. (NASDAQ: CLRX) and Medytox Solutions, Inc. (OTCQB: MMMS) (“Medytox”) have entered into a non-binding letter of intent to negotiate a potential business combination. Also, CollabRx and Medytox announced that they have entered into agreements that would secure funding needed by CollabRx to continue to operate while the parties negotiate a…
-
Investor’s Alert: Mylan (NASDAQ:MYL), C&J Energy Services (NYSE:CJES), Acorn Energy (NASDAQ:ACFN), Mastech Holdings (NYSEMKT:MHH), Black Box Corporation (NASDAQ:BBOX)
Theravance Biopharma, Inc. and Mylan Inc. (NASDAQ:MYL) Monday announced a partnership for development and commercialization of TD-4208, an investigational once-daily nebulized long-acting muscarinic antagonist or LAMA for chronic obstructive pulmonary disease or COPD and other respiratory diseases. On Friday shares of Mylan, Inc. (NASDAQ:MYL) closed at $53.15. Company’s sales growth for last 5 years was…
-
Keep Eyes on: Novavax (NASDAQ:NVAX), Microsoft Corporation (NASDAQ:MSFT), AO Smith Corp. (NYSE:AOS), Mylan (NASDAQ:MYL), Live Nation Entertainment (NYSE:LYV)
Novavax (NASDAQ:NVAX) has received an average recommendation of “Buy” from the seven brokerages that are presently covering the company, Stock Ratings News reports. Seven analysts have rated the stock with a buy recommendation. On Tuesday shares of Novavax, Inc. (NASDAQ:NVAX) closed at $7.82. Company’s sales growth for last 5 years was 80.20%. Investors wiped $35…
-
Mix Sector Stocks News: Vitae Pharmaceuticals (NASDAQ:VTAE), American Airlines (NASDAQ:AAL), ID Systems Inc. (NASDAQ:IDSY), Mylan (NASDAQ:MYL), QuickLogic Corporation (NASDAQ:QUIK)
Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), a clinical stage biotechnology company, on 23 January announced the pricing of its follow-on public offering of 3,000,000 shares of its common stock at $11.90 per share. All shares of common stock to be sold in the offering are being offered by Vitae. Vitae has also granted the underwriters a 30-day…
-
Traders Alert: Transgenomic Inc. (NASDAQ:TBIO), Anthera Pharmaceuticals (NASDAQ:ANTH), Mylan (NASDAQ:MYL), Stemline Therapeutics (NASDAQ:STML), Hess Corporation (NYSE:HES)
Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, on 14 January announced that the commercial launch of its Multiplexed ICE COLD-PCRTM (MX-ICP) product line is scheduled in the first quarter of 2015. MX-ICP is an ultra-high sensitivity…
-
Top Morning News: Mylan (NASDAQ:MYL), Fifth Third Bancorp (NASDAQ:FITB), Tesla Motors Inc (NASDAQ:TSLA), Gazit-Globe, (NYSE:GZT), Cyberonics Inc. (NASDAQ:CYBX)
Mylan Inc (NASDAQ:MYL) announced that its subsidiary Mylan Laboratories Limited is expanding its hepatitis C licensing agreement with Gilead Sciences (GILD) to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 and single tablet regimen of sofosbuvir/GS-5816, once approved, in 91 developing countries. On Monday shares of Mylan, Inc. (NASDAQ:MYL) closed…